Pitcairn Co. Increases Position in Colgate-Palmolive (NYSE:CL)

Pitcairn Co. lifted its position in shares of Colgate-Palmolive (NYSE:CL) by 8.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 10,388 shares of the company’s stock after purchasing an additional 787 shares during the period. Pitcairn Co.’s holdings in Colgate-Palmolive were worth $1,078,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of CL. Massachusetts Financial Services Co. MA boosted its holdings in shares of Colgate-Palmolive by 6.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after buying an additional 557,492 shares in the last quarter. Legal & General Group Plc boosted its stake in Colgate-Palmolive by 0.8% in the second quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock valued at $755,465,000 after acquiring an additional 61,413 shares in the last quarter. Acadian Asset Management LLC boosted its stake in Colgate-Palmolive by 108.4% in the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after acquiring an additional 2,955,442 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Colgate-Palmolive by 0.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 4,595,245 shares of the company’s stock worth $477,032,000 after purchasing an additional 11,750 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Colgate-Palmolive by 19.2% during the second quarter. Dimensional Fund Advisors LP now owns 3,503,450 shares of the company’s stock worth $340,006,000 after purchasing an additional 565,524 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.34% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Sanford C. Bernstein raised their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research note on Tuesday, July 30th. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research report on Monday, October 28th. TD Cowen reduced their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. JPMorgan Chase & Co. raised their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, Barclays upped their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a report on Monday, July 29th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Trading Up 0.7 %

Shares of CL stock opened at $94.92 on Monday. Colgate-Palmolive has a 1-year low of $75.50 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business’s fifty day moving average price is $98.10 and its 200 day moving average price is $98.57. The firm has a market capitalization of $77.55 billion, a PE ratio of 27.20, a P/E/G ratio of 3.36 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.11%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.